Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/183
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai
Description: Subject matter which includes a compound containing a ring composed of carbon and at least one element from the group consisting of nitrogen, sulfur, selenium, tellurium and oxygen as DOAI.


Sub-classes under this class:

Class Number Class Name Patents
514/184 Heavy metal containing (including salts) 555
514/191 Aluminum (including salts) 54
514/192 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.) 269
514/200 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) 180
514/210.01 Hetero ring is four-membered and includes at least one ring nitrogen 166
514/211.01 Hetero ring contains seven members including nitrogen, carbon and chalcogen 168
514/212.01 Hetero ring is seven-membered consisting of one nitrogen and six carbons 229
514/218 Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms 854
514/222.2 Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members 166
514/228.8 Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.) 266
514/241 Hetero ring is six-membered consisting of three nitrogens and three carbon atoms 587
514/247 Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) 743
514/277 Hetero ring is six-membered consisting of one nitrogen and five carbon atoms 866
514/359 Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) 597
514/430 Sulfur containing hetero ring 107
514/449 Oxygen containing hetero ring 562


Patents under this class:

Patent Number Title Of Patent Date Issued
6716831 2,4-diamino-pyrimidine deprivatives having anti-cell proliferative activity Apr. 6, 2004
6716832 Arylphenyl-substituted cyclic ketoenols Apr. 6, 2004
6716833 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors Apr. 6, 2004
6716836 Non-nucleoside reverse transcriptase inhibitors Apr. 6, 2004
6716874 Synergistic insecticide mixtures Apr. 6, 2004
6713467 Acid derivatives useful as serine protease inhibitors Mar. 30, 2004
6713468 Methods of using thiazolobenzoheterocycles Mar. 30, 2004
6710073 Drugs to improve synaptic transmission Mar. 23, 2004
6706702 Aryl fused azapolycyclic compounds Mar. 16, 2004
6706720 Heterocyclic dihydropyrimidine compounds Mar. 16, 2004
6703382 Small molecule inhibitors targeted at Bcl-2 Mar. 9, 2004
6703383 Antipsychotic sulfonamide-heterocycles, and methods of use thereof Mar. 9, 2004
6703384 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof Mar. 9, 2004
6703385 Tricyclic compounds having sPLA2-inhibitory activities Mar. 9, 2004
6699852 Substituted pyridoindoles as serotonin agonists and antagonists Mar. 2, 2004
6699853 4-HALOALKYL-3-HETEROCYCLYLPYRIDINES, 4-HALOALKYL-5-HETEROCYCLYL-PYRIMIDINES AND 4-TRIFLUOROMETHYL-3-OXADIAZOLYLPYRIDINES, PROCESSES FOR THEIR PREPARATION, COMPOSITIONS COMPRISING THEM, AND THE Mar. 2, 2004
6699854 Anti-cancer compounds Mar. 2, 2004
6696434 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases Feb. 24, 2004
6696435 Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity Feb. 24, 2004
6693091 Analogs of terpene trilactones from Ginkgo biloba for bioorganic and imaging studies Feb. 17, 2004
6693092 Arylphenyl-substituted cyclic ketoenols Feb. 17, 2004
6689398 Triterpene compositions and methods for use thereof Feb. 10, 2004
6689769 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections Feb. 10, 2004
6689770 Aryl sulfonyls as factor Xa inhibitors Feb. 10, 2004
6689771 Amide derivatives as inhibitors of matrix metalloproteinases, TNF-.alpha., and aggrecanase Feb. 10, 2004
6689772 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors Feb. 10, 2004
6689773 Uracil substituted phenyl sulfamoyl carboxamides Feb. 10, 2004
6689775 Uses of thioredoxin Feb. 10, 2004
6689782 Fungal efflux pump inhibitors Feb. 10, 2004
6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia Feb. 10, 2004
6689801 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme Feb. 10, 2004
6686347 Phthalazine derivatives for treating inflammatory diseases Feb. 3, 2004
6686348 Metalloprotease inhibitors Feb. 3, 2004
6686358 Bicyclic amino-pyrazinone compounds Feb. 3, 2004
6686380 Treatment of refractory tumors using epothilone derivatives Feb. 3, 2004
6686387 Synergistic insecticidal mixtures Feb. 3, 2004
6683028 Cyclic guanidine derivatives and their use as pesticides Jan. 27, 2004
6680311 Cryptophycin compounds Jan. 20, 2004
6680312 Sulfonamide derivatives, their production and use Jan. 20, 2004
6677330 Fluorides of 4-substituted piperidine derivatives Jan. 13, 2004
6677368 4-aryl substituted indolinones Jan. 13, 2004
6673784 Electrophilic ketones for the treatment of herpesvirus infections Jan. 6, 2004
6673785 Use of hepoxilins or hepoxilin analogs as antidiabetics, antiinflammatory agents Jan. 6, 2004
6673786 Tryptase inhibitors Jan. 6, 2004
6673787 Sulfonamide-containing indole compounds Jan. 6, 2004
6673788 Electrophilic ketones for the treatment of herpesvirus infections Jan. 6, 2004
6673789 2-pyridinylguanidine urokinase inhibitors Jan. 6, 2004
6673807 Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins Jan. 6, 2004
6670348 Methods and compositions for destruction of selected proteins Dec. 30, 2003
6670354 Methods to enhance white blood cell count Dec. 30, 2003



 
 
  Recently Added Patents
System and method for handling device objects in a data storage environment for maintaining consistency during data replication
Method and apparatus for forming a wire to include coil segments
Passive self-tuning resonator system
Lighting device
Process for producing mycophenolic acid using Penicillium arenicola BICC 7673
External memory accessing DMA request scheduling in IC of parallel processing engines according to completion notification queue occupancy level
Medicinal composition
  Randomly Featured Patents
Method for production of acrylic acid
Treatment of tumors with autologous LAK cells, interleukin-2 and an ornithine decarboxylase inhibitor
Vacuum interrupter
Top for a canister
Semiconductor memory device
Method to avoid copper contamination on the sidewall of a via or a dual damascene structure
Process for charging silver electrodes to monoxide level
High-performance error-correcting codes with skew mapping
Hue and saturation control circuitry requiring single coupling capacitor
Method of product promotion